KFin Technologies Entity Re-classification of Capital Foods Private Limited Approved

KFin Technologies Limited announced on March 30, 2026, that it has successfully completed the re-classification of Capital Foods Private Limited (CFPL). CFPL, previously categorized under the ‘Promoter(s) Group,’ will now officially move to the ‘Public’ category. The company confirmed receipt of the necessary no-objection letters from both the BSE and the NSE, finalizing the procedural requirements related to this change.

Regulatory Clearance Secured for Entity Change

KFin Technologies Limited has finalized the administrative process concerning the change in the status of Capital Foods Private Limited (CFPL). On March 30, 2026, the company secured the requisite no-objection letters from both the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE).

Details of Re-classification

This development allows CFPL to transition out of the ‘Promoter(s) Group’ category and be officially recognized in the ‘Public’ category. This action was initiated following previous communications regarding an application filed seeking approval for this specific re-classification. The successful outcome means that CFPL ceases to be a part of the ‘Promoter(s) Group’ of KFin Technologies.

Timeline of Confirmation

The crucial information regarding the receipt of approval occurred on March 30, 2026, specifically at approximately 04:01 p.m. IST. The company confirmed that all details presented in the required summary form (Form A) are, to the best of the management’s knowledge, true, correct, and complete.

Summary of Disclosure

The entire disclosure process, documented in Form A, confirmed that there were no expected financial implications, no identified aberrations or non-compliances, and no penalties or restrictions imposed by the authorities in relation to this communication.

Source: BSE

Previous Article

IRCTC Intimation Regarding Change in Senior Management – Cessation of Sh. Sudeesh V C

Next Article

Jubilant Ingrevia Completion of 100% Acquisition of Remidex Pharma Private Limited